264 related articles for article (PubMed ID: 35565418)
1. Extracellular Vesicles in the Progression and Therapeutic Resistance of Nasopharyngeal Carcinoma.
Shan Y; Zhou P; Zhou Q; Yang L
Cancers (Basel); 2022 May; 14(9):. PubMed ID: 35565418
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus noncoding RNAs from the extracellular vesicles of nasopharyngeal carcinoma (NPC) cells promote angiogenesis via TLR3/RIG-I-mediated VCAM-1 expression.
Cheng S; Li Z; He J; Fu S; Duan Y; Zhou Q; Yan Y; Liu X; Liu L; Feng C; Zhang L; He J; Deng Y; Sun LQ
Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1201-1213. PubMed ID: 30659926
[TBL] [Abstract][Full Text] [Related]
3. LMP1-positive extracellular vesicles promote radioresistance in nasopharyngeal carcinoma cells through P38 MAPK signaling.
Zhang Z; Yu X; Zhou Z; Li B; Peng J; Wu X; Luo X; Yang L
Cancer Med; 2019 Oct; 8(13):6082-6094. PubMed ID: 31436393
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr viral product-containing exosomes promote fibrosis and nasopharyngeal carcinoma progression through activation of YAP1/FAPα signaling in fibroblasts.
Lee PJ; Sui YH; Liu TT; Tsang NM; Huang CH; Lin TY; Chang KP; Liu SC
J Exp Clin Cancer Res; 2022 Aug; 41(1):254. PubMed ID: 35986369
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus-encoded latent membrane protein 1 promotes extracellular vesicle secretion through syndecan-2 and synaptotagmin-like-4 in nasopharyngeal carcinoma cells.
Liao C; Zhou Q; Zhang Z; Wu X; Zhou Z; Li B; Peng J; Shen L; Li D; Luo X; Yang L
Cancer Sci; 2020 Mar; 111(3):857-868. PubMed ID: 31930596
[TBL] [Abstract][Full Text] [Related]
6. Updates on Epstein-Barr Virus (EBV)-Associated Nasopharyngeal Carcinoma: Emphasis on the Latent Gene Products of EBV.
Ahmed N; Abusalah MAHA; Farzand A; Absar M; Yusof NY; Rabaan AA; AlSaihati H; Alshengeti A; Alwarthan S; Alsuwailem HS; Alrumaih ZA; Alsayyah A; Yean CY
Medicina (Kaunas); 2022 Dec; 59(1):. PubMed ID: 36676626
[TBL] [Abstract][Full Text] [Related]
7. Vesicle-bound EBV-BART13-3p miRNA in circulation distinguishes nasopharyngeal from other head and neck cancer and asymptomatic EBV-infections.
Ramayanti O; Verkuijlen SAWM; Novianti P; Scheepbouwer C; Misovic B; Koppers-Lalic D; van Weering J; Beckers L; Adham M; Martorelli D; Middeldorp JM; Pegtel DM
Int J Cancer; 2019 May; 144(10):2555-2566. PubMed ID: 30411781
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus LMP1 manipulates the content and functions of extracellular vesicles to enhance metastatic potential of recipient cells.
Nkosi D; Sun L; Duke LC; Meckes DG
PLoS Pathog; 2020 Dec; 16(12):e1009023. PubMed ID: 33382850
[TBL] [Abstract][Full Text] [Related]
9. The role of Epstein-Barr virus infection in the pathogenesis of nasopharyngeal carcinoma.
Tsang CM; Tsao SW
Virol Sin; 2015 Apr; 30(2):107-21. PubMed ID: 25910483
[TBL] [Abstract][Full Text] [Related]
10. Nasopharyngeal Carcinoma and Its Microenvironment: Past, Current, and Future Perspectives.
Su ZY; Siak PY; Leong CO; Cheah SC
Front Oncol; 2022; 12():840467. PubMed ID: 35311066
[TBL] [Abstract][Full Text] [Related]
11. Platelet-derived extracellular vesicles inhibit ferroptosis and promote distant metastasis of nasopharyngeal carcinoma by upregulating ITGB3.
Li F; Xu T; Chen P; Sun R; Li C; Zhao X; Ou J; Li J; Liu T; Zeng M; Zheng W; Lin Y; Yang L; Li Z; Chen H; Zhang Q
Int J Biol Sci; 2022; 18(15):5858-5872. PubMed ID: 36263165
[TBL] [Abstract][Full Text] [Related]
12. EGFR-rich extracellular vesicles derived from highly metastatic nasopharyngeal carcinoma cells accelerate tumour metastasis through PI3K/AKT pathway-suppressed ROS.
Li F; Zhao X; Sun R; Ou J; Huang J; Yang N; Xu T; Li J; He X; Li C; Yang M; Zhang Q
J Extracell Vesicles; 2020 Oct; 10(1):e12003. PubMed ID: 33304472
[TBL] [Abstract][Full Text] [Related]
13. The role of extracellular vesicles in the development of nasopharyngeal carcinoma and potential clinical applications.
Liang T; Chen L; Liu X; Li Y; Li Z; Yang D; Li H
Cancer Med; 2023 Jul; 12(13):14484-14497. PubMed ID: 37306659
[TBL] [Abstract][Full Text] [Related]
14. Targeting Epstein-Barr virus oncoprotein LMP1-mediated high oxidative stress suppresses EBV lytic reactivation and sensitizes tumors to radiation therapy.
Hu J; Li Y; Li H; Shi F; Xie L; Zhao L; Tang M; Luo X; Jia W; Fan J; Zhou J; Gao Q; Qiu S; Wu W; Zhang X; Liao W; Bode AM; Cao Y
Theranostics; 2020; 10(26):11921-11937. PubMed ID: 33204320
[TBL] [Abstract][Full Text] [Related]
15. The immune escape mechanism of nasopharyngeal carcinoma.
Li X; Guo Y; Xiao M; Zhang W
FASEB J; 2023 Jul; 37(7):e23055. PubMed ID: 37358482
[TBL] [Abstract][Full Text] [Related]
16. Targeting Epstein-Barr Virus in Nasopharyngeal Carcinoma.
Hau PM; Lung HL; Wu M; Tsang CM; Wong KL; Mak NK; Lo KW
Front Oncol; 2020; 10():600. PubMed ID: 32528868
[TBL] [Abstract][Full Text] [Related]
17. Extracellular Vesicles in Cancer Drug Resistance: Roles, Mechanisms, and Implications.
Yang Q; Xu J; Gu J; Shi H; Zhang J; Zhang J; Chen ZS; Fang X; Zhu T; Zhang X
Adv Sci (Weinh); 2022 Dec; 9(34):e2201609. PubMed ID: 36253096
[TBL] [Abstract][Full Text] [Related]
18. EBV-miR-BART8-3p induces epithelial-mesenchymal transition and promotes metastasis of nasopharyngeal carcinoma cells through activating NF-κB and Erk1/2 pathways.
Lin C; Zong J; Lin W; Wang M; Xu Y; Zhou R; Lin S; Guo Q; Chen H; Ye Y; Zhang B; Pan J
J Exp Clin Cancer Res; 2018 Nov; 37(1):283. PubMed ID: 30477559
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus infection and nasopharyngeal carcinoma.
Tsao SW; Tsang CM; Lo KW
Philos Trans R Soc Lond B Biol Sci; 2017 Oct; 372(1732):. PubMed ID: 28893937
[TBL] [Abstract][Full Text] [Related]
20. EBV-miR-BART7-3p promotes the EMT and metastasis of nasopharyngeal carcinoma cells by suppressing the tumor suppressor PTEN.
Cai LM; Lyu XM; Luo WR; Cui XF; Ye YF; Yuan CC; Peng QX; Wu DH; Liu TF; Wang E; Marincola FM; Yao KT; Fang WY; Cai HB; Li X
Oncogene; 2015 Apr; 34(17):2156-66. PubMed ID: 25347742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
